In oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway

Abstract The disulfide isomerase ERp57, originally found in the endoplasmic reticulum, is located in multiple cellular compartments, participates in diverse cell functions and interacts with a huge network of binding partners. It was recently suggested as an attractive new target for cancer therapy...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tobias Ocklenburg, Fabian Neumann, Alexandra Wolf, Julia Vogel, Kirsten Göpelt, Melanie Baumann, Jennifer Baumann, Philip Kranz, Eric Metzen, Ulf Brockmeier
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/70c99fc6b9384a9d8053fe7ddefd8962
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:70c99fc6b9384a9d8053fe7ddefd8962
record_format dspace
spelling oai:doaj.org-article:70c99fc6b9384a9d8053fe7ddefd89622021-12-02T14:23:18ZIn oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway10.1038/s41598-021-86658-52045-2322https://doaj.org/article/70c99fc6b9384a9d8053fe7ddefd89622021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-86658-5https://doaj.org/toc/2045-2322Abstract The disulfide isomerase ERp57, originally found in the endoplasmic reticulum, is located in multiple cellular compartments, participates in diverse cell functions and interacts with a huge network of binding partners. It was recently suggested as an attractive new target for cancer therapy due to its critical role in tumor cell proliferation. Since a major bottleneck in cancer treatment is the occurrence of hypoxic areas in solid tumors, the role of ERp57 in cell growth was tested under oxygen depletion in the colorectal cancer cell line HCT116. We observed a severe growth inhibition when ERp57 was knocked down in hypoxia (1% O2) as a consequence of downregulated c-Myc, PLK1, PDPK1 (PDK1) and AKT (PKB). Further, irradiation experiments revealed also a radiosensitizing effect of ERp57 depletion under oxygen deprivation. Compared to ERp57, we do not favour PDPK1 as a suitable pharmaceutical target as its efficient knockdown/chemical inhibition did not show an inhibitory effect on proliferation.Tobias OcklenburgFabian NeumannAlexandra WolfJulia VogelKirsten GöpeltMelanie BaumannJennifer BaumannPhilip KranzEric MetzenUlf BrockmeierNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Tobias Ocklenburg
Fabian Neumann
Alexandra Wolf
Julia Vogel
Kirsten Göpelt
Melanie Baumann
Jennifer Baumann
Philip Kranz
Eric Metzen
Ulf Brockmeier
In oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway
description Abstract The disulfide isomerase ERp57, originally found in the endoplasmic reticulum, is located in multiple cellular compartments, participates in diverse cell functions and interacts with a huge network of binding partners. It was recently suggested as an attractive new target for cancer therapy due to its critical role in tumor cell proliferation. Since a major bottleneck in cancer treatment is the occurrence of hypoxic areas in solid tumors, the role of ERp57 in cell growth was tested under oxygen depletion in the colorectal cancer cell line HCT116. We observed a severe growth inhibition when ERp57 was knocked down in hypoxia (1% O2) as a consequence of downregulated c-Myc, PLK1, PDPK1 (PDK1) and AKT (PKB). Further, irradiation experiments revealed also a radiosensitizing effect of ERp57 depletion under oxygen deprivation. Compared to ERp57, we do not favour PDPK1 as a suitable pharmaceutical target as its efficient knockdown/chemical inhibition did not show an inhibitory effect on proliferation.
format article
author Tobias Ocklenburg
Fabian Neumann
Alexandra Wolf
Julia Vogel
Kirsten Göpelt
Melanie Baumann
Jennifer Baumann
Philip Kranz
Eric Metzen
Ulf Brockmeier
author_facet Tobias Ocklenburg
Fabian Neumann
Alexandra Wolf
Julia Vogel
Kirsten Göpelt
Melanie Baumann
Jennifer Baumann
Philip Kranz
Eric Metzen
Ulf Brockmeier
author_sort Tobias Ocklenburg
title In oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway
title_short In oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway
title_full In oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway
title_fullStr In oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway
title_full_unstemmed In oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway
title_sort in oxygen-deprived tumor cells erp57 provides radioprotection and ensures proliferation via c-myc, plk1 and the akt pathway
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/70c99fc6b9384a9d8053fe7ddefd8962
work_keys_str_mv AT tobiasocklenburg inoxygendeprivedtumorcellserp57providesradioprotectionandensuresproliferationviacmycplk1andtheaktpathway
AT fabianneumann inoxygendeprivedtumorcellserp57providesradioprotectionandensuresproliferationviacmycplk1andtheaktpathway
AT alexandrawolf inoxygendeprivedtumorcellserp57providesradioprotectionandensuresproliferationviacmycplk1andtheaktpathway
AT juliavogel inoxygendeprivedtumorcellserp57providesradioprotectionandensuresproliferationviacmycplk1andtheaktpathway
AT kirstengopelt inoxygendeprivedtumorcellserp57providesradioprotectionandensuresproliferationviacmycplk1andtheaktpathway
AT melaniebaumann inoxygendeprivedtumorcellserp57providesradioprotectionandensuresproliferationviacmycplk1andtheaktpathway
AT jenniferbaumann inoxygendeprivedtumorcellserp57providesradioprotectionandensuresproliferationviacmycplk1andtheaktpathway
AT philipkranz inoxygendeprivedtumorcellserp57providesradioprotectionandensuresproliferationviacmycplk1andtheaktpathway
AT ericmetzen inoxygendeprivedtumorcellserp57providesradioprotectionandensuresproliferationviacmycplk1andtheaktpathway
AT ulfbrockmeier inoxygendeprivedtumorcellserp57providesradioprotectionandensuresproliferationviacmycplk1andtheaktpathway
_version_ 1718391432412135424